DAVA Oncology is a strategic consulting company which offers numerous products and services customized to fit biopharmaceutical drug development needs.
DAVA’s trial acceleration services optimize the recruitment and retention of patients in cancer clinical trials using physician-focused approaches including education workshops, medical feasibility assessment, site ID, site motivation and referral outreach.
DAVA conducts non-CME, oncology-focused meetings under the Oncology Meeting Innovations name. There are three types of meetings: global summits, regional summits and expert forums. The goal of these programs is to improve the dissemination of knowledge between researchers, innovators and implementers in the treatment of cancer.
Leveraging the clinical and biopharmaceutical expertise of our MD team, the ONE oncology business unit offers consultative services and tools to the biopharmaceutical industry. Services include, but are not limited to, syndicated competitive intelligence tools, MD-led training, e-learning modules and qualitative market research.
October 10, 2020
